SCHEMBL23837809

SCHEMBL23837809

Cc1ncccc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 20/20 0.83
▸ ATRIP Q8WXE1 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17501635 0.91 ATR (1.00) ATRATRIP
SCHEMBL17501237 0.90 ATR (1.00) ATRATRIP
SCHEMBL30140422 0.90 ATR (1.00) ATRATRIP
SCHEMBL18109968 0.89 ATR (1.00) ATRATRIP
SCHEMBL17501603 0.89 ATR (1.00) ATRATRIP
SCHEMBL30140416 0.89 ATR (1.00) ATRATRIP
SCHEMBL23837808 0.89 ATR (0.80) ATRATRIP
SCHEMBL23837764 0.89 ATR (0.83) ATRATRIP
SCHEMBL17501362 0.89 ATR (1.00) ATRATRIP
SCHEMBL30140500 0.89 ATR (1.00) ATRATRIP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3395818-B1 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES Bayer Pharma AG (DE) 2021-09-22 — — EP disclosed
Send feedback